好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Teaching neurologists through microlearning: the first 4 years of the eLearning experience with NeuroBytes
好色先生, Research, and Methodology
P13 - Poster Session 13 (8:00 AM-9:00 AM)
15-001
Determine the impact of the AAN NeuroBytes eLearning program on learning and neurological practice.

NeuroBytes are brief multimedia videos that provide focused, clinically relevant topic updates in neurology. Neurobytes were launched in January 2019 to deliver microlearning in neurology. We assessed the impact of Neurobytes on satisfaction, learning, and practice.

We conducted a programmatic review to evaluate all NeuroBytes from January 2019 (launch) to date of analysis (October 2022). Each NeuroByte course included the video and a survey. Assessment data included: course enrollments, completion rate, satisfaction, and influence on practice. Course enrollment was defined as opening for viewing; course completion required completing the post-course survey which assessed user satisfaction and influence on practice. Data were stratified by user type. To assess the program’s impact, four primary outcomes were defined: (1) course enrollments, (2) course completion rate, (3) satisfaction rate, and (4) percent reporting a change in practice. Descriptive statistics were performed.

From Jan 2019 – Sept 2022 104 NeuroBytes were released. Total enrollments were 65,089; mean enrollments of 598+377 per course. Mean course completion was 39% (range 7% to 92%). On post-course survey, 87% were satisfied/extremely satisfied. Courses covered 20 subspecialties and COVID-19. The most frequent topics were neuromuscular (n=10) and vascular (n=9). The most popular NeuroByte courses were ‘Dual antiplatelet therapy in ischemic stroke’ (n=1,851 enrollments) and ‘The neurologic exam via telemedicine’ (n=1,848). Member neurologists accounted for 55% of course enrollments, followed by juniors (18%), non-AAN members (13%), APP (6%), or student (3%).
NeuroBytes are a successful microlearning tool for delivering continuing professional development. The primary strengths of the program are accessibility, high-yield learning, breadth of topics, and appeal to a range of learners. Not all content is conducive to micro-delivery. Ongoing efforts will define how this program influences daily practice and lifelong learning.
Authors/Disclosures
Adam Quick, MD (The Ohio State University)
PRESENTER 		The institution of Dr. Quick has received research support from NINDS. The institution of Dr. Quick has received research support from NEALS.
Alexandra M. Miller, MD (NYU Langone Department of Neurology) Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Modifi Biosciences.
James E. Siegler III, MD (University of Chicago) Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siegler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serb. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wallaby Phenox. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Precision Medicine, LLC. The institution of Dr. Siegler has received research support from Philips. The institution of Dr. Siegler has received research support from Medtronic.
Robert A. Rook (好色先生) Mr. Rook has nothing to disclose.
Michaela Morris (好色先生) Ms. Morris has nothing to disclose.
Zach Cramer (好色先生) Mr. Cramer has nothing to disclose.
Xiaoyu Sun (好色先生) Xiaoyu Sun has received personal compensation for serving as an employee of 好色先生. An immediate family member of Xiaoyu Sun has received personal compensation for serving as an employee of Syneos Health. An immediate family member of Xiaoyu Sun has stock in Syneos Health. An immediate family member of Xiaoyu Sun has stock in BioNTech.
Calli L. Cook, DNP, FNP-C, DAAN, FAAN (Emory Healthcare) Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer . Dr. Cook has a non-compensated relationship as a Board Member with Alliance for Patient Access that is relevant to AAN interests or activities.
Behnam Sabayan, MD, PhD, MSc, FAHA The institution of Dr. Sabayan has received research support from NIH. The institution of Dr. Sabayan has received research support from Lilly .
Jeff Kraakevik, MD, FAAN Dr. Kraakevik has stock in Multiple companies. The institution of Dr. Kraakevik has received research support from Parkinson Foundation. The institution of Dr. Kraakevik has received research support from Syngeric.
Jeremy Moeller, MD, FAAN (Yale University) Dr. Moeller has received publishing royalties from a publication relating to health care.
Richard S. Isaacson, MD, FAAN Dr. Isaacson has stock in Retain Health. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care.
Zachary N. London, MD, FAAN (University of Michigan) Dr. London has nothing to disclose.
Roy E. Strowd III, MD, FAAN (Wake Forest School Of Medicine) Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.